LFG
XENE icon

Larson Financial Group’s Xenon Pharmaceuticals XENE Stock Holding History

Larson Financial Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Sell
3
-49
-94% -$2.72K ﹤0.01% 3613
2026
Q1 		$3.02K Buy
52
+50
+2,500% +$2.3K ﹤0.01% 2827
2025
Q4 		$90 Hold
2
– – ﹤0.01% 3346
2025
Q3 		$80 Buy
+2
New +$70 ﹤0.01% 3336
2023
Q4 		– Sell
-17
Closed -$581 – 1912
2023
Q3 		$581 Buy
+17
New +$636 ﹤0.01% 1559

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Larson Financial Group's XENE Position: Q2 2026 in Review

Larson Financial Group reduced its Xenon Pharmaceuticals (XENE) stake by 94% in Q2 2026, selling an estimated $2.72K and leaving 3 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #3613.

Larson Financial Group first reported a position in XENE in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.02K in Q1 2026. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Larson Financial Group held 3 shares of Xenon Pharmaceuticals worth $181 as of Q2 2026.
  • Larson Financial Group sold 49 Xenon Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3613 holding.
  • Larson Financial Group first reported a position in Xenon Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • Larson Financial Group's Xenon Pharmaceuticals position peaked at $3.02K in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.